Brussels, 3 July 2025

EuropaBio is pleased to note Commission recognition of biotechnology within the Life Sciences Strategy, with priorities for this cross-sectoral critical technology reflected in the key actions, including the dedicated Biotech Act.

The Strategy recognises the need for Innovation Principle-driven actions for biotech as a frontier technology, balanced with application-driven consumer and societal confidence for successful uptake and impact of products.

As an association, we look across the European Commission to work with ambition and collaboration. Each action should be impactful, with tangible benefits for the delivery of biotechnology to market and citizens from the strength of EU research. This will then deliver a Europe that is a globally attractive hub for innovation and industry.

EuropaBio Director General Dr Claire Skentelbery added “All of these actions have significant potential. We call upon policy makers to be thoughtful in their development so that each is a generation defining tool for the EU”.